Wednesday, 19 November 2014

ScHARRNews - Wednesday 19th November 2014



Early Access to Medicines Scheme
On 7 April 2014 the Early Access to Medicines Scheme (EAMS) was launched. EAMS aims to give patients with life threatening or seriously debilitating conditions access to medicines that do not yet have a marketing authorisation when there is a clear unmet medical need.Under the scheme, the Medicines and Healthcare products Regulatory Agency (MHRA) will provide a scientific opinion on the benefit/ri
Living with Stroke...
Nasrin Nasr and her Crucible partners Dr Carmen Levick, Dr Clare Howarth, Dr Nina Lueck, Dr Jorge Martins, Dr Vincenzo Leo have been successful in gaining seed funding for "Life with Stroke" project. The project is an interdisciplinary cross-faculty collaboration with Theatre studies, Neuroscience, Organisational informatics, Law and stroke survivors experts. The aim of the project is to


Scientists identify a rise in life-threatening heart infection
Scientists at the University of Sheffield have identified a significant rise in the number of people diagnosed with a serious heart infection alongside a large fall in the prescribing of antibiotic prophylaxis to dental patients.
Pioneering anti-clotting medication halves stent blockage in heart attack patients
Treating heart attack patients with ticagrelor reduces the risk of stents blocking with blood clots according to a ground breaking new study conducted by researchers from the University of Sheffield.
Message for NHS EED database users
From January 2015 no new records/commentaries will be added to NHS EED. Existing content will continue to be accessible via the CRD site. NIHR funding to produce NHS EED ceases at the end of March 2015."From 1 April 2015 the NIHR's Dissemination Centre will make available new summaries of research which has been identified as important to clinicians, patients and managers. For some, commentar
Microsoft's new mHealth Platform
To learn about the first big mHealth move by Microsoft since earlier this year. Please visit this website!

No comments:

Post a Comment